Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 12 citing articles:

Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19
Bibo Zhu, Xiaoqin Wei, Harish Narasimhan, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Open Access | Times Cited: 23
Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID‐19: A systematic review and meta‐analysis
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
Recent Advances and Future Prospects of Treatment of Pulmonary Hypertension
Adrija Hajra, Israel Safiriyu, Prasanth Balasubramanian, et al.
Current Problems in Cardiology (2022) Vol. 48, Iss. 8, pp. 101236-101236
Open Access | Times Cited: 13
Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19
Teodor Salmen, Valeria-Anca Pietroșel, Bianca-Margareta Mihai, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2624-2624
Open Access | Times Cited: 11
Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
Jean Kim, Kyle Miyazaki, Parthav Shah, et al.
Healthcare (2022) Vol. 10, Iss. 4, pp. 645-645
Open Access | Times Cited: 10
The impact of innovative glucose-lowering drugs on the course and outcome of COVID-19 in patients with type 2 diabetes mellitus
Т. Н. Маркова, M. Stas
Diabetes Mellitus (2024) Vol. 27, Iss. 2, pp. 174-184
Open Access | Times Cited: 1
Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy
Vincenzo Maria Monda, Claudio Voci, Felice Strollo, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 12, pp. 2127-2142
Open Access | Times Cited: 3
Susceptibility to recombinant SARS‐CoV‐2 spike protein entry in the lungs of high‐fat diet‐induced obese mice
Koro Gotoh, Fumiko Satoh, Honami Uesugi, et al.
The FASEB Journal (2024) Vol. 38, Iss. 10
Closed Access
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
Miodrag Janić, Sabina Škrgat, Matevž Harlander, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2030-2030
Open Access
The impact of antidiabetic medications on COVID-19 outcomes in diabetic patients: an overview
Malek Zarei, Navideh Sahebi vaihan, Sepideh Shiravand, et al.
Deleted Journal (2024) Vol. 28, Iss. 4, pp. 363-388
Open Access
Research Progress of Perioperative Application of GLP-1 and Its Protective Effects on Organs
Xi Hong, Zhigang Pang, Yifan Liu, et al.
Journal of Clinical and Nursing Research (2023) Vol. 7, Iss. 4, pp. 19-28
Open Access
Antidiabetic Drugs in COVID-19
Niki Katsiki, Maciej Banach
Contemporary cardiology (2022), pp. 351-364
Closed Access
Page 1

Scroll to top